Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Jones Lang LaSalle Inc (JLL) Price & Performance

AbCellera Biologics IncTrade
Jones Lang LaSalle IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Jones Lang LaSalle Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 5.6× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.

ABCLJLL
Market Cap
$2.99B$16.72B
Sector
HealthReal Estate
52-Week High
$9.76$373.24
52-Week Low
$2.78$280.16
Enterprise Value
$2.58B$19.48B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL